Cisplatin (P) versus cyclophosphamide, adriamycin and cisplatin (CAP) for stage III-IV epithelial ovarian carcinoma: a prospective randomized trial. [electronic resource]
Producer: 19890306Description: 573-7 p. digitalISSN:- 0300-8916
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma -- drug therapy
- Cisplatin -- adverse effects
- Cyclophosphamide -- adverse effects
- Doxorubicin -- adverse effects
- Female
- Humans
- Middle Aged
- Ovarian Neoplasms -- drug therapy
- Peptichemio -- adverse effects
- Prospective Studies
- Random Allocation
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.